[

astrazeneca

]

Latest from astrazeneca

AstraZeneca nasal spray vaccine for Covid fizzles in small, early trial

The spray vaccine didn’t provide a consistently strong immune response in the nasal mucosa tissue or in the rest of the body, University of Oxford researchers said in a statement.

AstraZeneca nasal spray vaccine for Covid fizzles in small, early trial(REUTERS)
AstraZeneca nasal spray vaccine for Covid fizzles in small, early trial(REUTERS)
Published on Oct 11, 2022 07:14 AM IST
Bloomberg |

AstraZeneca's Farxiga cuts death risk in heart failure patients: Report

The drug belongs to a class of medicines called SGLT2 inhibitors that were initially approved to treat type 2 diabetes. Since then, the drugs have been shown to benefit patients with chronic kidney and heart disease and prevent heart attacks.

Representational image. 
Representational image. 
Published on Aug 27, 2022 09:14 PM IST
Reuters |

AstraZeneca on hunt for deals, but may not stay in vaccines: Report

Production delays, probes by regulators following rare cases of severe side effects and concerns about its relatively short shelf life compared with other shots have stymied adoption of AstraZeneca's Covid-19 vaccine.

The logo of AstraZeneca.(REUTERS)
The logo of AstraZeneca.(REUTERS)
Published on Aug 23, 2022 07:44 PM IST
Reuters | , London

Opinion: UK's accidental AstraZeneca + Pfizer vaccine = better Omicron immunity?

The UK's mix-and-match approach to vaccinations looks accidentally brilliant.

Opinion: UK's accidental AstraZeneca + Pfizer vaccine = better Omicron immunity?(Representational Image / REUTERS)
Opinion: UK's accidental AstraZeneca + Pfizer vaccine = better Omicron immunity?(Representational Image / REUTERS)
Updated on May 31, 2022 12:20 PM IST
Bloomberg |

AstraZeneca vaccine booster shot effective against Omicron: Oxford lab study

The study found that antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from Covid-19.

The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, US. (REUTERS)
The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, US. (REUTERS)
Published on Dec 23, 2021 01:19 PM IST
Reuters |
Story Saved
×
Saved Articles
Following
My Reads
My Offers
Sign out
New Delhi 0C
Monday, January 30, 2023
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals